Imaging
Cor Pulmonale
- Preliminary Diagnosis: Cor Pulmonale
-
I. What imaging technique is first-line for this diagnosis?
- II. Describe the advantages and disadvantages of this technique for diagnosing cor pulmonale.
-
III. What are the contraindications for the first-line imaging technique?
-
IV. What alternative imaging techniques are available?
- V. Describe the advantages and disadvantages of the alternative techniques for diagnosing cor pulmonale.
-
VI. What are the contraindications for the alternative imaging techniques?
Preliminary Diagnosis: Cor Pulmonale
I. What imaging technique is first-line for this diagnosis?
2-D echocardiography.
II. Describe the advantages and disadvantages of this technique for diagnosing cor pulmonale.
Advantages
Does not expose patients to ionizing radiation.
Highly sensitive and specific in detecting cardiac abnormalities and detailing the source of abnormality (valvular, pericardial, vascular).
Able to detail cardiovascular and chamber pressures, allowing better characterization of the primary abnormality and/or any secondary complications.
Better able to direct treatment and therapy than other imaging modalities.
Disadvantages
Highly operator dependent.
III. What are the contraindications for the first-line imaging technique?
No specific contraindications to echocardiography.
IV. What alternative imaging techniques are available?
Plain radiography (PA and lateral view of the chest).
V. Describe the advantages and disadvantages of the alternative techniques for diagnosing cor pulmonale.
Advantages
Relatively quick, portable, and inexpensive imaging modality.
Exposes patients to minimal ionizing radiation.
Disadvantages
Has limited sensitivity and specificity in clinching a diagnosis and characterizing cor pulmonale.
Less adept in detailing surrounding soft tissue, vascular, and osseous structures.
VI. What are the contraindications for the alternative imaging techniques?
No contraindications to plain radiography exist. Some institutions may require signed consent for pregnant women.
Copyright © 2017, 2014 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |